
Tazinova P 4000mg/500mg Injection
Marketer
Innova Formulations Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazinova P 4000mg/500mg Injection
Cefoperazone/Sulbactam 4000mg/500mg injection is a dual-antibiotic formulation combating diverse bacterial infections by eliminating microorganisms. Administered solely by medical personnel, dosage and frequency are determined by a physician based on individual health conditions. Strict adherence to prescribed usage is essential. Potential side effects encompass nausea, vomiting, diarrhea, and skin rashes, alongside injection site reactions such as pain, swelling, or inflammation. Persistent or worsening symptoms warrant immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver ailments to your doctor, who may adjust the dosage or select an alternative medication. Generally considered safe under medical guidance during pregnancy and lactation.
Uses of Tazinova P 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazinova P 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Tazinova P 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazinova P 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazinova P 4000mg/500mg Injection works:
The injectable formulation Tazinova P (4000mg piperacillin/500mg tazobactam) unites two distinct agents to combat bacterial infections. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby augmenting piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from co-ingesting alcohol and Tazinova P 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazinova P, 4000mg/500mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazinova P, 4000mg/500mg, poses no known breastfeeding risk. Research in humans indicates minimal to negligible drug transfer into breast milk, resulting in no discernible harm to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tazinova P 4000mg/500mg Injection on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Tazinova P 4000mg/500mg Injection cautiously. Dosage modification for Tazinova P 4000mg/500mg Injection might be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazinova P 4000mg/500mg Injection in patients with liver impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Tazinova P 4000mg/500mg Injection :
Omit a Tazinova P 4000mg/500mg Injection dose? Seek medical advice immediately.
Facts to Know About Tazinova P 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
